NSCLC neoadjuvant setting | |
NSCLC neoadjuvant setting | |
nivolumab based treatment | |
nivolumab plus SoC | CheckMate 816 |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -